Tech »  Topic »  Sale of 23andMe: On the Hot Seat of Congress, States

Sale of 23andMe: On the Hot Seat of Congress, States


Lawmakers Quiz Execs on Security; State AG Seek to Block Sale of Bankrupt Firm Marianne Kolbasuk McGee (HealthInfoSec) • June 10, 2025

23and Me's founder and former CEO Anne Wojcicki, interim CEO Joseph Selsavage and law professor Margaret Hu testified before a Congressional committee about the bankrupt genetic testing firm's upcoming sale. (Image: U.S. Congress)

Twenty-eight state attorneys general have filed a lawsuit to block the sale of bankrupt consumer genetics testing firm 23andMe to the highest bidder without the company obtaining explicit consent from each customer for the transfer or their information to a third party.

See Also: The Healthcare CISO's Guide to Medical IoT Security

Two companies are currently bidding for 23andMe - biotech firm Regeneron Pharmaceuticals and the nonprofit medical research organization TTAM Research Institute, which was founded by Anne Wojcicki, co-founder and former CEO of 23andMe.

While Regeneron entered into a purchase agreement last ...


Copyright of this story solely belongs to bankinfosecurity . To see the full text click HERE